The commercial stakes are considerable. The global organic acids market is projected to reach 36.86 billion dollars by 2026, and in 2004 the United States Department of Energy identified twelve high-priority building-block chemicals obtainable from biomass, roughly seventy percent of which are organic acids. These include succinic acid, 3-hydroxypropionic acid, itaconic acid, and levulinic acid, compounds that serve as precursors for biodegradable plastics, solvents, pharmaceuticals, and food additives. Traditionally these chemicals come from petrochemical synthesis or heterotrophic fermentation, both of which carry substantial carbon footprints. Cyanobacteria offer a third route: photoautotrophic biosynthesis that consumes the greenhouse gas responsible for climate change as its raw material.

The metabolic logic behind this capability is elegant. Cyanobacteria fix atmospheric carbon dioxide through the Calvin-Benson-Bassham cycle, generating central intermediates such as pyruvate, phosphoenolpyruvate, and acetyl-CoA that feed into the tricarboxylic acid cycle. From these nodes, carbon can be channeled into acetate, lactate, citrate, succinate, fumarate, and malate. Intriguingly, cyanobacteria possess an atypical, incomplete TCA cycle lacking the canonical 2-oxoglutarate dehydrogenase complex. Instead, they bypass this step via 2-oxoglutarate decarboxylase and succinic semialdehyde dehydrogenase, an evolutionary adaptation that appears designed to preserve carbon skeletons for biosynthesis rather than burning them off as carbon dioxide. Some strains also harbor the glyoxylate shunt and a gamma-aminobutyric acid shunt, alternative routes that connect carbon metabolism with nitrogen assimilation and redox regulation.

The organisms also display a striking diurnal rhythm that researchers are learning to exploit. During daylight, cyanobacteria assimilate carbon dioxide into glycogen stores; when darkness falls and oxygen dwindles, they ferment these reserves, secreting organic acids and hydrogen. Under dark, anoxic conditions, Synechocystis sp. PCC 6803 has been shown to release more than 400 milligrams per liter of acetate, along with lactate, succinate, and malate, independent of nitrogen source. This natural overflow metabolism acts as a redox-balancing mechanism, dumping excess reducing equivalents when the cell’s usual sinks, such as glycogen and protein synthesis, are unavailable. Engineers are now working to redirect this flux deliberately toward single target products under continuous illumination.

Case studies demonstrate how far metabolic engineering can push these yields. In Synechocystis PCC 6803, inserting a codon-optimized phosphoketolase from Pseudomonas aeruginosa boosted acetate production fortyfold, and co-expressing phosphotransacetylase raised titers to 2.3 grams per liter, an eightyfold increase over the starting strain. Lactate engineering has been even more dramatic: combining overexpression of malic enzyme and d-lactate dehydrogenase with deletion of the acetate kinase gene produced a record 26.6 grams per liter of d-lactate from high-density cell cultures after seventy-two hours of fermentation. Because lactate is the monomer for polylactic acid, a biodegradable plastic used in packaging and 3D printing, such strains could eventually supply the bioplastics industry with carbon-negative feedstock.

Succinate, a top Department of Energy platform chemical used to make 1,4-butanediol, gamma-butyrolactone, and biodegradable polymers, has seen similar success. In Synechococcus elongatus PCC 7942, researchers used CRISPR interference to repress glycogen synthesis and succinate dehydrogenase while overexpressing key carboxylation and decarboxylation enzymes, achieving the highest cyanobacterial succinate titer reported to date: 4.8 grams per liter in twenty-eight days, rising to 8.9 grams per liter with reinoculation. A separate photomixotrophic strategy engineered the same strain to import glucose at low pH and export succinate at high pH, exploiting opposing proton symporters to reach 5.0 grams per liter in ten days. Even citrate, long considered too tightly regulated to accumulate, has been produced photoautotrophically in PCC 7002 using a theophylline-responsive riboswitch to throttle TCA flux, yielding more than a hundredfold increase over wild type.

Redox engineering has emerged as a central theme in these efforts. Cyanobacteria inherently produce abundant NADPH through photosynthesis, yet many fermentative enzymes prefer NADH, creating a cofactor mismatch that limits yields. Solutions include overexpressing transhydrogenases such as PntAB to interconvert the two pools, and site-directed mutagenesis to swap enzyme cofactor preferences, as demonstrated with an NADH-dependent lactate dehydrogenase from Lactobacillus bulgaricus that was redesigned to accept NADPH. Environmental tuning matters too: raising cultivation temperature from 30 to 37 degrees Celsius enhanced d-lactate and succinate production in PCC 6803, while mildly acidic conditions increase passive secretion of weak acids by boosting membrane permeability. Nitrogen starvation can push glycogen-deficient strains into a photo-catalytic state, continuously excreting alpha-ketoglutarate and pyruvate even without growth.

Formidable obstacles remain before these microbes can compete with petrochemical plants. Cyanobacteria grow slowly, allocate only a minor fraction of fixed carbon to target products, and suffer from genetic instability, low transformation efficiency, and byproduct formation as carbon leaks into competing pathways. Product recovery is another bottleneck: organic acids exist in ionized form at neutral pH, and traditional acidification with mineral acids generates mountains of inorganic salt waste. Photobioreactors struggle with uneven light penetration, limited gas transfer, and biofouling, and techno-economic and life-cycle assessments for engineered cyanobacterial systems remain scarce, making it difficult to judge commercial feasibility. Most studies to date remain at proof-of-concept or laboratory scale.

The road ahead is nonetheless rich with opportunity. Emerging tools include CRISPR-based gene repression and activation, riboswitches and light-inducible promoters that decouple growth from production, and adaptive laboratory evolution to breed acid-tolerant strains. Machine learning-guided flux modeling and multi-omics integration are converting strain design from trial-and-error into predictive optimization, while next-generation photobioreactors with optical waveguides and gas-permeable membranes promise better scalability. Co-cultures with heterotrophs, photomixotrophy using waste-derived carbon, and multi-product biorefineries coupling organic acids with biofuels and bioplastics could further improve economics. Greener recovery technologies, including membrane filtration, electrodialysis, and in situ product removal, are being developed to replace salt-generating acidification. If these threads converge, cyanobacteria could transform sunlight and carbon dioxide into the molecular backbone of a circular, fossil-free chemical economy, turning the planet’s oldest oxygen-makers into its newest industrial workhorses.

Subject of Research: Metabolic engineering of cyanobacteria for sustainable photosynthetic production of organic acids

Article Title: Advances in organic acid production using cyanobacteria: strategies and applications

Article References: Pathania, R., & Srivastava, A. (2025). Advances in organic acid production using cyanobacteria: strategies and applications. Blue Biotechnology, 2(1), Article 22. https://doi.org/10.1186/s44315-025-00045-7

Image Credits: AI Generated

DOI: 10.1186/s44315-025-00045-7

Keywords: cyanobacteria, organic acids, metabolic engineering, synthetic biology, carbon dioxide fixation, succinate, lactate, TCA cycle, bioplastics, photobioreactors, CRISPRi, sustainable biomanufacturing

The research, led by Thanyaporn Tengsuttiwat, Howbeer Muhamadali, and Royston Goodacre at the University of Liverpool, together with colleagues at Aberystwyth University and Thailand’s National Center for Genetic Engineering and Biotechnology, focused on a classic model system: seven strains of E. coli N4830-1 engineered to produce cytochrome b5, a small heme-containing protein that turns the bacteria visibly pink when expressed. The strains, designated N0 through N6, carry between zero and six copies of the cyt b5 gene on plasmids under the control of a temperature-sensitive lambda PL promoter. At 30 degrees Celsius the promoter remains silent, but shifting the culture to 38.5 degrees Celsius releases the lambda cI857 repressor and switches on production synchronously across the entire population, without the need for chemical inducers.

To interrogate the metabolic consequences of this induction, the team employed gas chromatography coupled with mass spectrometry, or GC-MS, an analytical technique prized for its sensitivity and its coverage of central carbon and nitrogen metabolism. Bacterial cultures were rapidly quenched with pre-chilled methanol to freeze metabolism in place, intracellular metabolites were extracted through freeze-thaw cycling, and the dried extracts were chemically derivatised to make them volatile enough for GC analysis. The instrument, an Agilent 8890 GC fitted with a quadrupole time-of-flight mass spectrometer, generated raw data on 861 metabolic features, which the researchers rigorously curated down to 340 high-quality features using internal standards, pooled quality controls, and strict filtering criteria based on reproducibility and chromatographic peak shape.

The statistical treatment was equally careful. Principal component analysis, a chemometric method that compresses thousands of measurements into a few interpretable axes, cleanly separated induced from non-induced cultures along the first principal component, which alone explained more than 41 percent of the total variance. A semi-supervised extension called principal component discriminant function analysis then revealed something striking: among the induced samples, the metabolic profiles arranged themselves along a trajectory that tracked the gene copy number, from strain N0 to N6, even though the algorithm had never been told the ordering. The trend was not perfectly linear, however, hinting that regulatory constraints and adaptive stress responses, rather than gene dosage alone, shape the metabolic landscape during production.

Mapping the significant metabolites onto known E. coli pathways exposed the energetic heart of the burden. Metabolites of the tricarboxylic acid cycle, including citrate, isocitrate, fumarate, and oxaloacetate, together with glycolytic intermediates such as pyruvate, lactate, and 3-phosphoglycerate, were all significantly depleted in the cytochrome b5-producing strains. The pentose phosphate pathway and the glyoxylate shunt showed parallel depletions. The authors interpret this pattern as evidence of a substantially elevated demand for ATP, the universal cellular energy currency, consistent with earlier reports that glycolytic flux in E. coli is tightly controlled by the cell’s energy requirements and that recombinant protein synthesis drives increased flux through energy-generating pathways.

One particularly telling observation involved nicotinamide, a precursor of the essential redox cofactor NAD. Its concentration declined progressively with increasing cyt b5 gene copy number across strains N0 to N4, and tryptophan, from which nicotinamide can be biosynthesised, also shifted significantly between conditions. This suggests that the cofactor supply system itself was being drawn upon to support the redox demands of recombinant expression, providing a potential metabolic bottleneck that strain engineers could target.

The study also documented how the bacteria remodel their membranes and cell walls in response to the double insult of heat induction and protein overproduction. Glycerol, glycerol-3-phosphate, ethanolamine, and O-phosphoethanolamine, all intermediates in phospholipid biosynthesis, changed significantly, as did several unsaturated fatty acids including oleic acid, elaidic acid, and palmitoleic acid, which decreased under induction. N-acetylglucosamine, a building block of the bacterial cell wall, was markedly reduced. These changes echo the well-known homeoviscous adaptation by which bacteria adjust membrane lipid composition to maintain fluidity at elevated temperatures, and they indicate that the cell envelope is a major site of metabolic reconfiguration during recombinant production.

Stress responses left equally clear fingerprints. The polyamines putrescine, cadaverine, and spermidine, compounds known to accumulate under heat, osmotic, oxidative, and ultraviolet stress, were all detected, with putrescine declining while cadaverine and its catabolic derivative 5-aminovaleric acid rose under induction. Alterations in purine and pyrimidine metabolites, including hypoxanthine, thymine, 5,6-dihydrouracil, and orotic acid, pointed to impacts on nucleotide biosynthesis, while changes in glutamine, glutamate, serine, and tryptamine reflected pressure on amino acid pools. Because the experimental design included a control strain carrying the plasmid backbone but no cyt b5 gene, the team could partially disentangle the effects of the 8.5-degree temperature shift itself from those of protein production, concluding that heat induction is the dominant driver of metabolic reprogramming, with gene copy number modulating specific features on top of that response.

The authors are candid about the limitations of their untargeted approach. Absolute quantification was not possible, and the absence of a dedicated washing step means some detected compounds may have originated from the nutrient-rich LB medium rather than from endogenous synthesis. They propose that future work combine intracellular metabolic profiling with metabolic footprinting, lipidomics, targeted quantitative assays, adenylate energy charge measurements, and 13C-based fluxomics to fully characterise the burden and pinpoint bottlenecks. Even so, the findings demonstrate that cytochrome b5 production triggers coordinated adjustments across energy metabolism, cell envelope biosynthesis, nucleotide metabolism, and stress responses. As the global recombinant protein market, valued at roughly 3.25 billion US dollars in 2024, is projected to approach 8.66 billion by 2034, understanding these hidden metabolic costs at pathway level offers a practical roadmap for engineering bacterial hosts and culture conditions that deliver more protein per cell, with less waste of the cell’s own precious energy.

Subject of Research: GC-MS metabolic profiling of recombinant cytochrome b5 production and its metabolic burden in E. coli N4830-1

Article Title: Metabolic profiling analysis of cytochrome b5 production in E. coli N4830-1 using GC-MS

Article References: Metabolic profiling analysis of cytochrome b5 production in E. coli N4830-1 using GC-MS. (n.d.). https://doi.org/10.1007/s11306-026-02522-5

Image Credits: AI Generated

DOI: 10.1007/s11306-026-02522-5

Keywords: metabolomics, GC-MS, E. coli, cytochrome b5, recombinant protein production, metabolic burden, TCA cycle, chemometrics, membrane remodeling, stress response, biotechnology, Metabolomics journal

Diabetic cardiomyopathy, the condition at the heart of this work, is a distinct disease entity characterized by ventricular dysfunction that arises without coronary artery disease or hypertension. It is a leading cause of death among people with type 2 diabetes, and its pathogenesis is notoriously multifaceted, involving metabolic disruption, chronic inflammation, oxidative stress, and fibrosis. Under hyperglycemic conditions, myocardial cells burn oxygen abnormally fast, generating excessive reactive oxygen species that damage mitochondrial structure and undermine cardiac contractility. Faulty respiratory chain complexes leak electrons, producing superoxide and driving a self-reinforcing spiral of mitochondrial dysfunction and cell loss through apoptosis and necrosis.

Current clinical strategies for diabetic cardiomyopathy focus on glycemic control, improving myocardial remodeling, easing heart failure, and reducing risk factors, yet the mechanisms of many cardioprotective drugs remain poorly understood, particularly regarding mitochondrial and metabolic dysfunction. This gap has pushed researchers toward natural products with multi-target potential, and astragaloside IV has already shown promise in preclinical models of diabetic nephropathy and cardiomyopathy, with documented antioxidant, anti-inflammatory, and anti-apoptotic activities. What remained unclear was precisely which molecular and metabolic changes the compound triggers to protect cardiomyocytes from diabetic injury.

To find out, the researchers exposed human AC16 cardiomyocytes to a high-glucose environment of 33 millimolar, mimicking the diabetic milieu, and then treated them with astragaloside IV. Viability testing with the CCK-8 assay showed that while the compound itself was toxic at 30 micromolar and above, concentrations of 10 and 20 micromolar significantly rescued the survival of high-glucose-injured cells. Microscopy confirmed that high glucose induced morphological damage, while astragaloside IV restored near-normal cell appearance. Flow cytometry quantified the benefit: cells treated with the compound showed markedly reduced apoptosis compared to untreated high-glucose controls. The team standardized on 10 micromolar for all subsequent experiments.

The transcriptomic arm of the study yielded striking results. RNA sequencing of control, model, and treatment groups, each with six biological replicates, revealed that high glucose dysregulated nearly 3,000 genes, with 2,182 upregulated and 801 downregulated relative to controls. Principal component analysis showed complete separation between control and model clusters, confirming that the damage model was robustly established. After astragaloside IV intervention, the treatment group clustered between the two, and only 596 genes remained differentially expressed compared to controls, a dramatic narrowing indicating that the compound largely reversed the transcriptional chaos wrought by hyperglycemia.

To prioritize the most relevant genes, the researchers intersected their differential expression results with cuproptosis-related gene sets drawn from the OMIM and GeneCards databases and the literature, an approach the authors emphasize was purely an exploratory bioinformatics framework rather than evidence that copper-induced cell death occurred. Nineteen core candidate genes emerged at the intersection of disease, model, and treatment signatures. Seven machine learning algorithms, all achieving perfect classification with an area under the curve of 1.0, were used to rank these genes, and a random forest model narrowed the list to eight. PDHA1, SLC25A3, VEGFA, SERPINE1, and CDKN2A carried the highest feature importance. Functional enrichment placed PDHA1 squarely in alpha-lipoic acid metabolism and the tricarboxylic acid cycle, while other genes mapped to cellular senescence, the Hippo pathway, HIF-1 signaling, and the AGE-RAGE axis implicated in diabetic complications.

On the metabolic side, targeted liquid chromatography-mass spectrometry profiling in positive and negative ionization modes identified 60 differential metabolites between control and model cells, and 37 of these were reversed by astragaloside IV. Quality control samples showed coefficients of variation mostly below 20 percent, and supervised OPLS-DA models achieved excellent fit statistics, with R-squared Y and Q-squared values above 0.95 in both modes, confirming the statistical credibility of the group separations. Among the metabolites significantly elevated by the compound were glutathione, oxidized glutathione, S-lactoylglutathione, DL-malic acid, and fumarate, while L-phenylalanine, galactose, and several phosphate intermediates declined. Random forest and support vector machine models independently converged on five key metabolites: 2-prime-deoxyadenosine 5-prime-monophosphate, cytidine 3-prime-monophosphate, epinephrine, oxidized glutathione, and DL-malic acid.

The TCA cycle itself told a subtler story. Six cycle intermediates were measured, including succinic, isocitric, oxaloacetic, malic, aconitic, and fumaric acids, and their changes were heterogeneous rather than uniformly restored. DL-malic acid and fumarate rose significantly after astragaloside IV treatment, while isocitrate and oxaloacetate fell, and succinate and aconitate trended upward without reaching significance. The authors interpret this as a selective reorganization within the cycle rather than a wholesale recovery of the entire metabolic profile. Malate is a pivotal intermediate, regenerating oxaloacetate through mitochondrial malate dehydrogenase and shuttling redox equivalents between cytoplasm and mitochondria via the malate-aspartate shuttle, so its partial restoration hints at rebalanced substrate utilization and redox homeostasis. Spearman correlation analysis added an intriguing twist: most core genes, including PDHA1, showed significant negative correlations with DL-malic acid, suggesting coordinated transcriptional and metabolic remodeling during high-glucose stress and recovery, though the authors are careful to note that correlation does not establish causation.

Canonical correlation analysis strengthened the case for integrated regulation, yielding correlation coefficients of 0.985 and 0.931 for the first two gene-metabolite variate pairs. Pathway enrichment ranked the TCA cycle and pyruvate metabolism as the most significantly affected pathways by topology-based impact values, placing mitochondrial energy metabolism at the center of both the diabetic injury response and the compound’s protective action. Molecular docking then provided computational support for a direct physical interaction: astragaloside IV docked to PDHA1, the E1-alpha subunit of the pyruvate dehydrogenase complex, with a binding energy of minus 8.3 kilocalories per mole, while DL-malic acid bound at minus 6.1, both well within the threshold considered indicative of high affinity. PDHA1 catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA, the gateway reaction linking glycolysis to the TCA cycle, and its expression rose under sustained high glucose, likely a compensatory response to altered substrate utilization, before being partially restored by treatment.

The authors are candid about the study’s limits. The work rests on an in vitro cell model that cannot capture the systemic metabolic and vascular abnormalities of diabetic cardiomyopathy, and the multi-omics evidence is associative and hypothesis-generating rather than proof of causal mechanism. Docking scores reflect structural compatibility, not biochemical binding or enzymatic regulation. The team plans to validate the PDHA1 interaction using surface plasmon resonance, cellular thermal shift assays, and enzyme activity measurements, to deploy knockdown and overexpression approaches, to conduct targeted metabolic flux analyses, and to extend the work into db/db mice. Still, the convergence of evidence is compelling: astragaloside IV appears to protect cardiomyocytes by rebalancing pyruvate metabolism, reshaping TCA cycle intermediates, and sustaining mitochondrial energy homeostasis. If validated in vivo, a compound derived from a medicinal root long used to strengthen the heart may offer a metabolically informed route to defending it against diabetes.

Subject of Research: Multi-omics analysis of astragaloside IV-mediated TCA cycle and mitochondrial metabolic remodeling in diabetic cardiomyocytes

Article Title: Multi-omics analysis reveals TCA cycle and mitochondrial metabolic remodeling associated with astragaloside IV-mediated cardioprotection

Article References: Chai, J., Wang, Y., Zhang, X., Wang, X., Wang, Z., Guo, S., Cai, Y., Xie, D., Yu, X., Qiu, S., & Zhang, A. (2026). Multi-omics analysis reveals TCA cycle and mitochondrial metabolic remodeling associated with astragaloside IV-mediated cardioprotection. Journal of Agriculture and Food Research, 31, Article 103303. https://doi.org/10.1016/j.jafr.2026.103303

Image Credits: AI Generated

DOI: 10.1016/j.jafr.2026.103303

Keywords: astragaloside IV, diabetic cardiomyopathy, TCA cycle, mitochondrial metabolism, PDHA1, pyruvate metabolism, multi-omics, transcriptomics, metabolomics, molecular docking, DL-malic acid, AC16 cardiomyocytes

Acute kidney injury, or AKI, affects a substantial share of hospitalized patients and carries significant short-term mortality and long-term risk of chronic kidney disease. At the cellular level, the damage concentrates in the proximal tubular epithelial cells, the workhorse cells of the nephron that normally rely overwhelmingly on mitochondrial oxidative phosphorylation to power massive reabsorption of solutes. When ischemia cuts off oxygen, these cells suffer a bioenergetic collapse: ATP production plummets, mitochondrial homeostasis is disrupted, and the tricarboxylic acid cycle, the central hub of oxidative metabolism, grinds toward inactivity. In a desperate bid to survive, the cells pivot to glycolysis, generating ATP from glucose without oxygen. That metabolic switch produces lactate as its signature byproduct, and lactate accumulation has long been regarded as a passive marker of the injury. The new study asks a sharper question: is lactate merely a bystander, or is it an active driver of the mitochondrial failure that follows?

To answer it, the researchers assembled evidence from three complementary systems: human renal biopsy specimens from patients with AKI, a murine model of ischemia/reperfusion-induced AKI, and proximal tubular epithelial cells challenged in vitro with hypoxia followed by reoxygenation. Across all three, they documented the same sequence. Ischemia/reperfusion inflicted a pronounced bioenergetic deficit in the proximal tubules, characterized by disrupted mitochondrial homeostasis, suppressed activity of TCA cycle genes, and enhanced aerobic glycolysis. Crucially, the lactate that accumulated during reperfusion was not inert. When the team blocked lactate production with sodium oxamate, a well-established inhibitor of lactate dehydrogenase, tubular injury was attenuated and oxidative metabolism was partially restored, indicating that lactate actively impairs mitochondrial oxidative metabolism rather than simply reflecting it.

The mechanistic trail then led to an unexpected player: MRS2, the mitochondrial RNA splicing 2 protein, which functions as the dominant channel for magnesium uptake into mitochondria. In the patient biopsies, serum lactate levels were positively correlated with renal MRS2 expression, hinting that the metabolic waste product and the magnesium channel were linked in human disease. Follow-up experiments in cells and mice confirmed the connection. Lactate accumulation increased mitochondrial magnesium uptake in an MRS2-dependent manner, driving an overload of magnesium ions inside the organelles. That overload, the study found, inhibits citrate synthase, the enzyme that catalyzes the first committed step of the TCA cycle. The consequence is a vicious loop: glycolysis generates lactate, lactate triggers MRS2-mediated magnesium influx, magnesium excess throttles the TCA cycle, and the crippled oxidative machinery forces the cell to lean even harder on glycolysis, producing more lactate.

Technical measurements anchored the claim. The team assessed mitochondrial function and oxidative metabolism using oxygen consumption rate assays, which quantify how efficiently mitochondria consume oxygen to generate ATP, alongside direct measurements of ATP production, mitochondrial membrane potential, and expression of TCA cycle genes. In the injured tubules, these readouts collapsed in parallel with rising lactate and rising MRS2 activity. When MRS2 was suppressed, either pharmacologically with the inhibitor CPACC or genetically with siRNA, mitochondrial oxidative metabolism rebounded, lactate accumulation fell, and renal injury following ischemia/reperfusion was attenuated. The genetic approach was delivered in vivo using lipid nanoparticles, the same class of delivery vehicles that carried mRNA vaccines into clinical use, encapsulating siMRS2 and silencing the channel in kidney tissue.

The therapeutic implications are striking because MRS2 offers a defined molecular handle on a process that has resisted intervention. Current management of ischemic AKI remains largely supportive, centered on hemodynamic optimization, avoidance of nephrotoxins, and, in severe cases, dialysis, while the underlying metabolic failure runs its course. A metabolism-based strategy that interrupts the lactate–MRS2 axis could, in principle, preserve mitochondrial function during the vulnerable reperfusion window and prevent the transition from reversible injury to established organ damage. The lipid nanoparticle delivery of siMRS2 demonstrated in this study provides a proof of concept that the target is druggable in living animals, and CPACC offers a small-molecule starting point for medicinal chemistry.

The study also reframes lactate itself. Long treated as a metabolic waste product or, in the Warburg tradition of cancer biology, as a hallmark of deranged metabolism, lactate is increasingly recognized as a signaling molecule with receptor-mediated and epigenetic effects. This work adds a subcellular dimension to that picture: lactate acting on the mitochondrial magnesium channel to reshape bioenergetics from within. In the kidney, where proximal tubular cells have minimal glycolytic capacity relative to their oxidative demands, such signaling may be particularly consequential, explaining why the glycolytic shift that sustains other cell types during hypoxia becomes maladaptive in the tubule.

Important caveats remain. The findings derive from biopsy specimens, a mouse model, and cell culture, and the translation of MRS2 inhibition to human therapy will require safety evaluation, since mitochondrial magnesium handling is fundamental to organelle function throughout the body. The timing of any intervention also matters, because reperfusion injury unfolds over hours and the therapeutic window must be defined precisely. The authors note that the article was shared early as a citable, peer-reviewed accepted version subject to further edits, and the work was supported by the National Natural Science Foundation of China, the National Key Research and Development Program of China, and Shanghai municipal science programs. Corresponding authors Yiqin Shi, Xiaoqiang Ding, and Nana Song led the collaboration, with Zhixin Yan, Annan Chen, and Fang Li as co-first authors.

Even with those qualifications, the study delivers a coherent and clinically resonant mechanism: hypoxia-driven lactate overproduction sustains maladaptive metabolic reprogramming through MRS2-dependent mitochondrial magnesium overload and citrate synthase inhibition. It explains why the kidney’s metabolic switch after ischemia becomes a trap rather than a rescue, and it converts that explanation into testable targets. If subsequent work confirms that blunting the lactate–MRS2 pathway protects human kidneys during surgery, transplantation, and shock, the humble end product of glycolysis may graduate from biomarker to bullseye, and the mitochondria of the proximal tubule may finally get the chance to resume the oxidative work upon which the entire organ depends.

Subject of Research: The lactate–MRS2 pathway driving maladaptive metabolic reprogramming in ischemia/reperfusion-induced acute kidney injury

Article Title: Lactate drives maladaptive metabolic reprogramming via MRS2 in ischemia/reperfusion-induced acute kidney injury

Article References: Yan, Z., Chen, A., Li, F., Zhang, J., Xie, Q., Han, G., Zhou, W., Yusufu, A., Chen, W., Gu, Q., Zhao, S., Yang, Y., Wang, J., Fang, Y., Li, Y., Dai, Y., Jin, S., Shi, Y., Ding, X., & Song, N. (2026). Lactate drives maladaptive metabolic reprogramming via MRS2 in ischemia/reperfusion-induced acute kidney injury. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06402-y

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06402-y

Keywords: acute kidney injury, ischemia/reperfusion, lactate, MRS2, mitochondrial magnesium overload, metabolic reprogramming, citrate synthase, proximal tubular epithelial cells, TCA cycle, lipid nanoparticle siRNA, mitochondrial dysfunction, sodium oxamate

The story begins with branched-chain amino acids: valine, leucine, and isoleucine, three of the twenty building blocks of proteins that plants and animals share. For decades these molecules were viewed mainly as structural components, but plant biologists have come to appreciate that under stress, amino acids moonlight as signaling molecules, osmotic protectants, antioxidant precursors, and, crucially, as fuel. When soluble sugars run out during periods of environmental duress, plants break down proteins and oxidize the freed amino acids in mitochondria to keep their energy supply running. Branched-chain amino acids are particularly effective at this, delivering some of the highest ATP yields of any amino acid group when completely oxidized. What remained murky was whether this metabolic strategy mattered specifically for heavy metal tolerance, and if so, which genes controlled it.

To find out, the team first conducted a systematic census of the BCAT gene family in cotton. BCAT, or branched-chain amino acid aminotransferase, sits at a metabolic crossroads, catalyzing both the final step of branched-chain amino acid biosynthesis and the first committed step of their degradation. Mining the genomes of four cotton species, the researchers identified 47 BCAT genes in total: 16 in the cultivated tetraploid Gossypium hirsutum, 15 in its tetraploid relative Gossypium barbadense, and just 8 each in the diploid progenitors Gossypium arboreum and Gossypium raimondii. The doubling pattern in the tetraploids pointed clearly to whole-genome duplication as the engine of this gene family’s expansion. Phylogenetic analysis, which placed the cotton proteins alongside BCATs from Arabidopsis, soybean, poplar, grapevine, and cacao, sorted the family into three clades, and chromosomal mapping showed homologous copies distributed across both the At and Dt subgenomes of Gossypium hirsutum, further evidence of allopolyploidization at work.

With the family catalogued, the next question was which members actually respond to cadmium. Using quantitative reverse-transcription PCR on the cadmium-tolerant cotton cultivar Zhong H242, the researchers tracked the expression of all 16 GhBCAT genes under 4 millimolar cadmium stress and found that most responded, with GhBCAT1, GhBCAT2, GhBCAT4, GhBCAT9, GhBCAT10, and GhBCAT12 showing especially strong upregulation after 12 hours of exposure. In roots, GhBCAT4 and GhBCAT12 were the standouts. Because GhBCAT12 maintained high expression across roots, stems, and leaves and exhibited the most pronounced stress response, it became the focus of functional validation. Promoter analysis added a layer of regulatory context: the GhBCAT promoters harbor hormone-responsive elements tied to jasmonate, auxin, gibberellin, abscisic acid, and salicylic acid, along with stress elements associated with hypoxia, drought, and low temperature, suggesting these genes sit at a busy intersection of hormone and stress signaling networks.

Where a protein operates inside the cell often reveals what it does, so the team set out to localize GhBCAT12. Computational prediction with Target P-2.0 assigned the protein a high-confidence mitochondrial transit peptide, and an experimental check sealed the verdict: when a GhBCAT12-GFP fusion was expressed alongside a fluorescent mitochondrial marker in tobacco leaves, the green and red signals overlapped completely under the confocal microscope. This subcellular address is metabolically meaningful. In plants, BCAT enzymes in chloroplasts tend to build branched-chain amino acids, while their mitochondrial counterparts tend to break them down. A mitochondrial GhBCAT12 therefore pointed toward degradation rather than synthesis, and its position within the organelle that houses the tricarboxylic acid cycle suggested a direct pipeline from amino acid oxidation to energy production.

To test whether that pipeline matters under cadmium stress, the researchers used virus-induced gene silencing to knock down GhBCAT12 in cotton seedlings and then challenged the plants with 4 millimolar cadmium. The effect was dramatic. Silenced plants wilted and dehydrated sooner than controls, accumulated significantly more malondialdehyde and hydrogen peroxide, showed denser superoxide staining with nitroblue tetrazolium, and displayed enlarged zones of cell death under trypan blue staining, a signature of damaged membranes and dying tissue. Superoxide dismutase activity rose in the silenced plants, indicating that the antioxidant system was straining to compensate. The phenotypes confirmed GhBCAT12 as a positive regulator of cadmium tolerance rather than a bystander, echoing work in rice where the degradation-oriented OsBCAT2 bolsters salt tolerance and OsDIAT promotes drought resistance through branched-chain amino acid metabolism.

Metabolomic profiling then supplied the mechanistic thread. In GhBCAT12-silenced plants, leucine, isoleucine, and valine all accumulated, with leucine and isoleucine rising significantly, consistent with a stalled degradation pathway, while acetyl-CoA levels fell. Because acetyl-CoA is the carbon currency that feeds the tricarboxylic acid cycle, its scarcity translated directly into an energy shortfall: leaf ATP contents dropped in parallel. The researchers checked whether transcriptional suppression of key cycle enzymes such as citrate synthase GhCS6 or isocitrate dehydrogenase GhIDH1 could explain the decline and found no significant differences, ruling out that mechanism. Instead, the NADH to NAD+ ratio was significantly lower in silenced plants, a pattern consistent with constrained cycle flux caused by insufficient carbon substrate rather than dampened gene expression. In short, the data support an interpretation in which impaired branched-chain amino acid degradation starves the cycle of acetyl-CoA, throttling mitochondrial ATP synthesis.

Why would that matter for a heavy metal? The answer lies in the vacuole, the large central compartment where plant cells stash toxic cadmium. Transporters of the ABC and heavy metal ATPase families pump cadmium from the cytoplasm into the vacuole, and their activity is strictly ATP-dependent. Subcellular fractionation revealed the consequences: silenced plants carried significantly more cadmium in their cell wall and soluble fractions and significantly less in the organelle fraction, indicating that vacuolar sequestration had weakened and the metal was loitering where it could do damage. The team then performed a decisive rescue experiment. Supplying exogenous ATP at an optimized concentration of 400 micromolar alleviated the wilting phenotype of GhBCAT12-silenced plants, reduced malondialdehyde and hydrogen peroxide accumulation, restored leaf ATP content, and, critically, shifted cadmium back into the organellar, vacuolar fraction while reducing its cytoplasmic burden. This causal chain, from amino acid catabolism to acetyl-CoA to ATP to vacuolar sequestration, is the study’s central contribution, and it reframes cadmium tolerance as an energy logistics problem, not merely a transport or chelation problem.

The implications reach beyond cotton biology. GhBCAT12 could serve as a molecular marker for screening cadmium-tolerant germplasm, and moderate enhancement of its expression, or tuning of its enzymatic activity through gene editing, might yield cotton varieties that thrive on contaminated land while keeping cadmium out of the fiber and out of the food chain. The authors are appropriately cautious about the limits of their evidence: virus-induced gene silencing is transient and awaits confirmation through stable genetic approaches, and the conclusion that GhBCAT12 preferentially degrades leucine and isoleucine rests on indirect metabolic evidence that in vitro enzyme assays have yet to confirm. The reason silenced shoots accumulated more cadmium than controls also remains unresolved. Even so, the work reveals a previously hidden axis of heavy metal tolerance that connects mitochondrial metabolism, cellular energetics, and detoxification compartmentalization. As industrialization and agrochemical overuse continue to spread cadmium through farmland, understanding how a single mitochondrial aminotransferase can power a plant’s self-defense offers both a compelling piece of basic science and a practical lead for breeding crops that can grow where the soil is poisoned, turning an ancient metabolic pathway into a modern tool for agricultural resilience.

The energy economics of heavy metal detoxification help explain why a metabolic gene would matter so much here. Pumping cadmium into the vacuole is an ongoing expense for the cell, because ABC transporters and heavy metal ATPases hydrolyze ATP with each transport cycle, and the metal must be moved continuously as exposure persists. A tolerance strategy therefore depends not just on having the right transporters, but on sustaining the ATP supply that feeds them, which is precisely the link the GhBCAT12 pathway addresses.

Branched-chain amino acids are well suited to this role from a bioenergetic standpoint. Their complete oxidation feeds acetyl-CoA and succinyl-CoA into the tricarboxylic acid cycle and can also supply electrons directly to the mitochondrial electron transport chain, giving them among the highest energy yields of the amino acid family. This is why BCAA catabolism becomes central during carbon starvation, and cadmium stress appears to co-opt the same fuel-switching logic.

The gene family’s history in cotton is also instructive. The near-doubling of BCAT members in the tetraploid species relative to their diploid ancestors illustrates how whole-genome duplication provides raw material for stress adaptation, allowing duplicated copies to specialize in response to particular challenges. Comparative work in rice and barley showing BCAT genes tied to salt and drought tolerance suggests this is a conserved monocot and dicot strategy, with cotton now adding heavy metal tolerance to the list of stresses governed by this metabolic crossroads.

Subject of Research: Cadmium tolerance mechanisms in cotton mediated by branched-chain amino acid metabolism and vacuolar sequestration

Article Title: Cadmium tolerance mediated by GhBCAT12 through branched-chain amino acid degradation via vacuolar sequestration in cotton

Article References: Xiao, L., Chen, X., He, Y., Kong, D., Wang, J., Yang, J., Cui, Y., Huang, H., Zhao, K., Wang, J., Lan, H., Song, R., Wu, F., Zhang, X., Yu, X., Zhu, J., Liu, J., Zhou, S., Tian, X., … Ye, W. (2026). Cadmium tolerance mediated by GhBCAT12 through branched-chain amino acid degradation via vacuolar sequestration in cotton. Stress Biology, 6(1), Article 59. https://doi.org/10.1007/s44154-026-00335-z

Image Credits: AI Generated

DOI: 10.1007/s44154-026-00335-z

Keywords: GhBCAT12, cadmium stress, cotton, branched-chain amino acids, acetyl-CoA, ATP, vacuolar sequestration, mitochondria, TCA cycle, heavy metal tolerance, Gossypium hirsutum, gene silencing